Terms: = Skin cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
11 results:
1. Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.
Cheraghlou S; Christensen SR; Leffell DJ; Girardi M
JAMA Dermatol; 2021 May; 157(5):531-539. PubMed ID: 33787836
[TBL] [Abstract] [Full Text] [Related]
2. Talimogene Laherparepvec for the Treatment of Advanced Melanoma.
Ott PA; Hodi FS
Clin Cancer Res; 2016 Jul; 22(13):3127-31. PubMed ID: 27146699
[TBL] [Abstract] [Full Text] [Related]
3. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Vieyra-Garcia PA; Wei T; Naym DG; Fredholm S; Fink-Puches R; Cerroni L; Odum N; O'Malley JT; Gniadecki R; Wolf P
Clin Cancer Res; 2016 Jul; 22(13):3328-39. PubMed ID: 26851186
[TBL] [Abstract] [Full Text] [Related]
4. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract] [Full Text] [Related]
5. Predictive value of biopsy specimens suspicious for melanoma: support for 6-mm criterion in the ABCD rule.
Soltani-Arabshahi R; Sweeney C; Jones B; Florell SR; Hu N; Grossman D
J Am Acad Dermatol; 2015 Mar; 72(3):412-8. PubMed ID: 25582536
[TBL] [Abstract] [Full Text] [Related]
6. A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
Wang E; Zhao Y; Monaco A; Uccellini L; Kirkwood JM; Spyropoulou-Vlachou M; Panelli MC; Marincola FM; Gogas H
PLoS One; 2012; 7(7):e40805. PubMed ID: 22911710
[TBL] [Abstract] [Full Text] [Related]
7. Expression of CD64 (FcγRI) in skin of patients with acute GVHD.
van Royen-Kerkhof A; Walraven V; Sanders EA; de Weger R; van Wichen DF; de Koning E; Thepen T; van de Winkel JG; Leusen JH
Bone Marrow Transplant; 2011 Dec; 46(12):1566-9. PubMed ID: 21243031
[TBL] [Abstract] [Full Text] [Related]
8. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
[TBL] [Abstract] [Full Text] [Related]
9. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake.
Benitez-Ribas D; Adema GJ; Winkels G; Klasen IS; Punt CJ; Figdor CG; de Vries IJ
J Exp Med; 2006 Jul; 203(7):1629-35. PubMed ID: 16785312
[TBL] [Abstract] [Full Text] [Related]
10. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod.
Wollenberg A; Wen S; Bieber T
Cytometry; 1999 Oct; 37(2):147-55. PubMed ID: 10486527
[TBL] [Abstract] [Full Text] [Related]
11. Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients.
Heidecke H; Eckert K; Schulze-Forster K; Maurer HR
Int J Immunopharmacol; 1997 Aug; 19(8):413-20. PubMed ID: 9568546
[TBL] [Abstract] [Full Text] [Related]
